Considering the pivotal role of neuroinflammation in AD pathogenesis, we evaluated the anti‐inflammatory properties of ramalin, particularly its effects on inducible NO synthase (iNOS) and NO, both of which are implicated in AD‐related synaptic dysfunction and neuronal loss [48, 49]. Here, NOS2 is linked to Alzheimer disease.